Wednesday broker round-up
4th Jul 2012 08:19
African Minerals: Jefferies keeps buy rating and 800p target. Anite: Jefferies raises target from 155p to 160p, buy rating retained. Barclays: Nomura downgrades from neutral to reduce, target cut from 268p to 210p. British American Tobacco: AlphaValue downgrades from add to reduce, target raised
Read moreSector movers: Miners track metals prices lower
23rd May 2012 15:59
Mining stocks were at the top of the fallers list on Wednesday as concerns over Greece's future continue to weigh on the global economic outlook. Metals prices sank on concerns that the Chinese economy may be affected greatly by Greece leaving the euro: investment bank China International Capital C
Read moreLondon pre-open: FTSE to suffer slight drop in early trading
8th May 2012 07:31
City sources predict the FTSE 100 will open down eight points from Friday's close of 5,655, following the UK bank holiday weekend which saw polital uncertainty resurface in Europe following the Greek and French elections. Andrew Moss, the Chief Executive Officer of insurance giant Aviva, has taken
Read moreSmith and Nephew's Bioventus JV now live
8th May 2012 07:17
Medical devices maker Smith and Nephew said that its Bioventus joint venture with Essex Woodlands is now up and running. Essex Woodlands, a specialist healthcare growth equity and venture capital firm, pitched in with Smith & Nephew (S&N) to further develop the S&N's Biologics and Clinical Therapie
Read moreFriday broker round-up
4th May 2012 09:21
AstraZeneca: UBS raises target from 3,400p to 3,500p, buy rating unchanged. BG Group: Nomura cuts target from 1,950p to 1,850p, buy rating kept. British Land: Jefferies upgrades British Land from hold to buy, targetupped from 517p to 543p. Dairy Crest: Jefferies initiates coverage with a buy reco
Read moreFriday tips round-up: Smith and Nephew, Millenium and Copthorne
4th May 2012 07:02
In the Times, Tempus won't be drawn on whether Smith and Nephew is a good buy. The firm, which makes components for knee and hip replacements has cut overheads, paid down debts and is doing well in the BRIC economies. But Tempus thinks the only real progress on the shares (currently trading at eig
Read moreLondon close: Gains pared after comments from ECB's Draghi
3rd May 2012 16:37
- Stocks pare gains after Draghi offers no hints - US economic data comes in mixed - Mining and oil stocks weigh on Footsie After a decent start, gains for London's FTSE 100 were pared late on after a European Central Bank (ECB) press conference failed to boost confidence, meaning that the index fi
Read moreSector movers: Antofagasta, Randgold lead miners lower
3rd May 2012 14:54
Falling metals prices and some disappointing trading updates from Antofagasta and Randgold Resources were weighing on the mining sector today. Copper prices were at a one-week low today after mixed economic data from the US and concerns over the Eurozone debt crisis - fuelled by some gloomy manufac
Read moreFTSE 100 movers: Smith and Nephew beat expectations
3rd May 2012 14:36
Shares in technology group Smith and Nephew marched ahead after profits and margins at medical beat both analysts' and management forecasts in the first quarter of 2012. Alcoholic drinks maker Diageo's was also on the up following its announcement that growth in the third quarter of its fiscal yea
Read moreLondon midday: Investors eye ECB decision as stocks edge higher
3rd May 2012 12:08
- Investors await ECB decision - Successful bond auctions in France, Spain - Mixed reception to barrage of corporate updates The Footsie had traded within a narrow range in morning trade after a strong start ahead of a closely watch interest rate decision from the European Central Bank (ECB) due th
Read moreBroker tips: Legal and General, Randgold, Smith and Nephew
3rd May 2012 10:47
Nomura has maintained its buy rating and 182p target price for insurance group Legal and General, saying that the firm's first quarter showed strong asset management inflows. The stock is trading at just 7.7 times 2012 earnings, compared with the UK sector average multiple of 9.6. "We think the sh
Read moreBroker snap: Upwards margin surprise at S and N, says Jefferies
3rd May 2012 10:30
Jefferies has reiterated its buy recommendation and 740p target price for medical devices group Smith and Nephew after a 'solid' first-quarter update this morning. Sales rose 3% on an underlying basis to $1,079m, bang in line with consensus estimates. Adjusted earnings per share (EPSA) came in at
Read moreThursday broker round-up
3rd May 2012 09:15
Afren: finnCap downgrades from buy to hold. Carnival: Shore Capital upgrades from hold to buy. CSR: Jefferies reiterates buy rating and 290p target. Fenner: Credit Suisse downgrades from outperform to neutral, target cut from 540p to 480p. Ferrexpo: Renaissance Capital upgrades from hold to buy.
Read moreLondon open: Stocks rise ahead of ECB decision
3rd May 2012 08:34
- Mixed reception to barrage of blue-chip corporate updates - ECB expected to maintains rates - Kesa in demand after Darty development The FTSE 100 rose strongly on Thursday morning, rebounding after a sharp fall the day before, with investors looking ahead to an interest rate decision from the Eur
Read moreSmith and Nephew beats first-quarter forecasts
3rd May 2012 07:54
Profits at medical technology group Smith and Nephew beat both analysts' and management forecasts in the first quarter of 2012, which it said was down to the actions being taken to reshape the company. Trading profit in the three months to March 31st increased by 5% year-on-year to $252m. US broker
Read more